Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo (Q95607913)
Jump to navigation
Jump to search
scientific article published on 28 March 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo |
scientific article published on 28 March 2020 |
Statements
Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo (English)
Stuart Weston
Christopher M. Coleman
Rob Haupt
James Logue
Krystal Matthews
Matthew B. Frieman
28 March 2020
1 reference
Identifiers
1 reference